Keyphrases
Selective Antagonist
100%
JDTic
100%
Receptor Antagonist
100%
Prototypic
66%
Derivative-based
33%
Single Administration
33%
U50,488
33%
Antinociception
33%
Nor-binaltorphimine (nor-BNI)
33%
Receptor Binding Affinity
33%
Potential Therapeutics
33%
High Selectivity
33%
Soft Drugs
33%
Isolated Tissue
33%
Receptor Signaling
33%
P-hydroxyphenyl
33%
Short-acting
33%
Piperidine
33%
Binding Selectivity
33%
Psychiatric Disorders
33%
Phenylpiperidine
33%
Opioid Receptor Binding
33%
Dimethyl
33%
High Affinity
33%
Kappa Opioid Receptor Antagonist
33%
Pharmacodynamic Properties
33%
Neuroscience
Receptor Antagonist
100%
Receptor
100%
In Vivo
40%
Binding Affinity
20%
Opiate
20%
Piperidine
20%
Receptor Binding
20%
Kappa Antagonists
20%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor Antagonist
100%
Receptor
100%
Opiate Receptor
20%
3,4 Dichloro N Methyl N [2 (1 Pyrrolidinyl)cyclohexyl]benzeneacetamide
20%
Kappa Antagonists
20%
Piperidine Derivative
20%
Pharmacodynamics
20%
Antinociception
20%